
EXACT Therapeutics AS
EXTX | XOSL
Overview
Corporate Details
- ISIN(s):
- NO0010852205 (+1 more)
- LEI:
- 2138006ZE5JAL39AGD55
- Country:
- Norway
- Address:
- Østre Aker vei 19, 0581 Oslo
- Website:
- https://www.exact-tx.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
We are EXACT Therapeutics AS (“EXACT-Tx”), a clinical-stage biopharmaceutical company developing a novel ultrasound-mediated technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® is a unique approach to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy and immunotherapy), infectious diseases, and neurological conditions. EXACT Therapeutics and our ACT® platform builds on decades of R&D efforts within ultrasound and microbubbles performed by the former world leading diagnostic company; Nycomed Imaging AS (now GE Healthcare). In the late 1990’s and early 2000’s the core technology behind ACT® was developed, with more than $10 M and 40 man-years invested into establishing formulation, manufacturing line, quality control etc.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-04 09:20 |
Declaration of Voting Results & Voting Rights Announcements
EXACT Therapeutics AS – Information regarding voting at the Annual General Meet…
|
English | 1.7 KB | |
2025-05-28 14:53 |
General Meeting Notice
EXACT Therapeutics AS - Notice of Annual General Meeting 2025 - Attachment: AGM…
|
Norwegian | 1.1 MB | |
2025-05-28 14:53 |
General Meeting Notice
EXACT Therapeutics AS - Notice of Annual General Meeting 2025
|
English | 1.4 KB | |
2025-05-20 06:30 |
Earnings Release
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial i…
|
English | 115.9 KB | |
2025-05-20 06:30 |
Earnings Release
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial i…
|
English | 6.5 KB | |
2025-05-14 06:35 |
Regulatory News Service
EXACT Therapeutics announces grant of key patent covering non-invasive delivery…
|
English | 2.1 KB | |
2025-05-07 08:47 |
Regulatory News Service
EXACT Therapeutics announces grant of key patent in Japan
|
English | 1.9 KB | |
2025-04-09 19:17 |
Annual Report
EXACT Therapeutics - 2024 Annual Report
|
English | 4.9 MB | |
2025-04-09 19:17 |
Annual Report
EXACT Therapeutics - 2024 Annual Report
|
English | 1.6 KB | |
2025-01-28 07:00 |
Earnings Release
EXACT Therapeutics and Cordance Medical Announce Early Encouraging Data in Brai…
|
English | 3.3 KB | |
2024-10-08 08:04 |
Regulatory News Service
EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenu…
|
English | 4.2 KB | |
2024-10-02 06:30 |
Regulatory News Service
EXACT Therapeutics to Present at the bi-annual Contrast Media Research (CMR) Sy…
|
English | 3.2 KB | |
2024-09-30 06:00 |
Regulatory News Service
EXACT Therapeutics announces first half 2024 interim results
|
English | 547.1 KB | |
2024-09-30 06:00 |
Earnings Release
EXACT Therapeutics announces first half 2024 interim results
|
English | 2.8 KB | |
2024-09-25 07:00 |
Regulatory News Service
EXACT Therapeutics announces grant of immunotherapy patent
|
English | 107.3 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |